Dr. Charles Louis Alphonse Laveran

Hello! This comprehensive report will focus on the life, career, and significant contributions of Dr. Charles Louis Alphonse Laveran (1845-1922) to the field of protozoa-related diseases, including his discovery of the malaria parasite. As a French military doctor and parasitologist, Laveran was awarded the Nobel Prize in Physiology or Medicine in 1907 for his work on the role of protozoa in causing disease. This breakthrough marked a turning point in medical history, demonstrating that a single-celled protozoan could cause illness in humans. Laveran's research took place within the context of the germ theory of disease, which gained momentum at the end of the 19th century and beginning of the 20th century, as well as tropical medicine studies, influencing scientists of his time and leaving lasting impacts on modern medicine.

The Life and Career of Dr. Charles Louis Alphonse Laveran

Alphonse Laveran was born on June 18, 1845, in Paris, France. His father, Louis Théodore Laveran, was also a medical doctor who worked in military medicine. His mother was the daughter and granddaughter of high-ranking army officers. At a young age, Laveran moved to Algeria with his family. He later returned to Paris to complete his higher education, graduating from Collège Sainte-Barbe before earning a degree in natural sciences from Lycée Louis-le-Grand. Following in his father's footsteps, he decided to pursue a career in military medicine and enrolled at both the Imperial School of Military Health Services (École Impériale du Service de Santé Militaire) in Paris and the University of Strasbourg Faculty of Medicine in 1863. In 1866, he began working as an assistant physician in civilian hospitals in Strasbourg, and in 1867, he earned his medical diploma by presenting a thesis on nerve regeneration.

He joined the French Army upon the outbreak of the Franco-Prussian War (1870-1871). At the age of 29, he was appointed to the Chair of Military Diseases and Epidemics at the École de Val-de-Grâce. Upon completion of his term in 1878, he was sent to Bône in Algeria, where he worked until 1883. This period marked the beginning of his significant work on malaria and other tropical diseases.

Laveran served as Professor of Military Hygiene at the École de Val-de-Grâce from 1884 to 1889. He was later appointed Chief of the military hospital in Lille and then Director of Health Services for the 11th Corps in Nantes. In 1896, he joined the Pasteur Institute as Honorary Head of Service to devote himself full-time to research on tropical diseases. Laveran had a significant impact on developing research in the field of tropical medicine. In 1907, he established the Tropical Diseases Laboratory at the Pasteur Institute and founded the Société de Pathologie Exotique (Exotic Pathology Society) in 1908. During World War I, as a member of the Commission on Hygiene and Prophylaxis, he oversaw measures to prevent malaria among French troops deployed in various regions. He founded the Société de Pathologie Exotique in 1908 and led it for the next twelve years. For his efforts, he was awarded the prestigious Legion of Honor in 1912, created by Napoleon Bonaparte. Three years later, in 1915, on his 70th birthday, he became an Honorary Director of the Pasteur Institute.

Laveran died in Paris on 18 May 1922 at the age of 76.

Protozoa and Diseases: Basic Information

What Are Protozoa?

Protozoa are microscopic, single-celled eukaryotic organisms. Most protozoa species live freely, but every higher animal can be infected by one or more species of protozoa. Protozoal infections can range from asymptomatic to life-threatening, depending on the type of parasite and the host's resistance. Protozoa usually feed by engulfing and digesting other organisms. In food chains and webs they play various roles — as predators, herbivores, decomposers, and parasites. Protozoa are classified by their mode of movement into amoeboid (pseudopods), ciliate (cilia), flagellate (flagella), and sporozoan (non-motile) types. Their sizes range from about 1 to 200,000 micrometres.

Diseases Caused by Protozoa

Protozoa can cause various diseases in humans and animals. Some protozoal diseases known at the time of Laveran include:

Parasitic diseases caused by protozoa and helminths are a significant public health concern worldwide. These diseases, such as malaria and schistosomiasis, result in approximately 1.1 million deaths annually. The global burden of these diseases is further exacerbated by the lack of licensed vaccines.

The Discoveries That Led to Laveran's Nobel Prize

The Scientific and Experimental Methods Behind the Discovery

Throughout the 19th century, malaria was generally explained by the miasma theory of 'bad air'; foul vapours rising from marshland were believed to cause malarial fevers. At the end of the 1870s, however, with pioneers such as Louis Pasteur and Robert Koch establishing that microbes cause disease (the acceptance of germ theory), the search for the agent of malaria intensified.

In the scientific background, young French military doctor Alphonse Laveran was sent to Algeria for service in 1878 and began researching malaria there. Laveran challenged the prevailing view at the time by proposing that malaria was caused by a specific microorganism; as he put it, he predicted that marsh fevers were due to a germ (microbe).

In Constantine, Algeria, Laveran began examining blood samples from malaria patients at the military hospital to test his hypothesis. On October 20, 1880, while examining fresh blood smears from a malaria patient under a microscope, he noticed almost transparent structures shaped like crescents (half-moons) containing small pigment points.

Previous researchers had observed dark brownish pigments in the blood and spleens of malaria victims (this pigment, known as hemozoin, forms from the digestion of red blood cell hemoglobin by parasites). Pathologists such as Rudolf Virchow had also encountered this pigment in the spleen and blood of malaria patients as early as 1849, but misinterpreted its origin as a product of splenic cells. However, when Laveran saw these pigment-containing structures, he hypothesized that they originated from a parasite living in the blood, prompting him to systematically investigate this new finding.

Laveran's experimental method was extremely meticulous and innovative: unlike most of his colleagues, he examined fresh, live blood samples without applying any stain. The microscope he used was of the dry-objective type, capable of about 400× magnification without a stain — at the limit of what was possible for observing organisms as small as protozoa at the time. Laveran did not stop at scattered observations: he carefully examined the blood of 200 different malaria patients and identified the crescent-shaped bodies he had described in 148 of them; by contrast he saw no such structures in the blood of any patient suffering from a disease other than malaria. These numbers strongly indicated that his finding was not a coincidence and was directly tied to malaria. Laveran also noted that quinine, the only effective malaria drug known at the time, made these parasitic structures disappear from the patients' blood — that is, the blood of malaria patients who had received quinine therapy no longer contained these parasites. This observation was among the first pieces of evidence that the structures were indeed the agent of malaria, since an effective drug eliminated them.

Laveran also described the parasite's developmental stages as he observed them under the microscope. Inside and around the red blood cells he saw structures in different forms: crescent- or oval-shaped bodies with pigment granules clustered in the centre; motionless, spherical, pigmented bodies; actively moving, also pigmented spherical bodies; and structures that emerged from these and moved like curling threads. The structures Laveran recorded in his 1880 notebook, accompanied by his own drawings, were in fact different life-cycle stages of the malaria parasite: in modern terminology, male and female gametocytes, the trophozoite (feeding and growth phase), and the schizont (replication phase). The emergence of the thread-like flagella that he observed in the blood smear is today known as the male gametocyte's exflagellation — the process by which, on exposure to the outside environment, it produces motile, sperm-like microgametes. When Laveran first saw these mobile filamentous structures, he immediately recognised that they moved freely outside the red blood cells, wriggling like little worms, and that they belonged to a living organism. This critical observation, which demonstrated the structures' vitality, fully convinced Laveran that the agent of malaria was a parasite; he duly reported having seen elements of parasitic origin and proposed that they formed a new organism. Laveran initially named this organism Oscillaria malariae (because of its quivering movements); after later terminological debates the genus was renamed Plasmodium, and the species Laveran discovered ultimately became known as Plasmodium falciparum.

On December 24, 1880, Laveran presented his findings to the Société Médicale des Hôpitaux de Paris medical society in Paris. In 1881, he published a detailed report describing his discovery in the Bulletin of the Hospitals' Medical Society and The Lancet. He described a new parasite found in the blood of malaria patients in all its forms and concluded that: On October 20 last, while examining the blood of a patient suffering from malaria under the microscope, I noticed elements appearing to be of parasitic origin among the red blood cells. Since then, I have examined 44 cases and found the same elements in 26 of them. I looked for these elements in vain in diseases other than malaria. In the same year, he published a 104-page monograph titled Malaria Cases' Parasitic Nature: Definition of a New Parasite Found in the Blood of Malaria Patients (Nature parasitaire des accidents de l'impaludisme: description d'un nouveau parasite) announcing the details of his discovery to the scientific world. This work was the first scientific discovery showing that a protozoan causes human disease, thus providing an important contribution to the still newly accepted germ theory, making Laveran a pioneer in this field.

Initial Scientific Reactions to the Discovery

When Laveran announced his discovery of the malarial parasite, it was met with skepticism within the scientific community. At his initial presentation in Paris in 1880, leading microbiologists and physicians of the time questioned whether what he had observed was actually a real parasite, suggesting that it might be degenerated red blood cells or artifacts instead. Some influential researchers at the time had already identified a bacterium as the cause of malaria: German pathologist Theodor Klebs and his Italian colleague Corrado Tommasi-Crudeli isolated a bacterium from marsh waters near Rome and named it Bacillus malariae, claiming that malaria was transmitted by this bacterium. Therefore, Laveran's claim that the cause of malaria was a protozoan rather than a bacterium contradicted existing beliefs and initially failed to convince. Notably, some prominent microbiologists of the time, including Robert Koch in Germany, approached Laveran's findings with caution; Koch remained unconvinced until 1887.

Despite this, Laveran did not give up and made great efforts to verify his findings. In 1882, he traveled to Rome with special permission, where he examined the blood of Italian malaria patients who had been infected from the famous Campagna marsh area. His research conducted at the Santo Spirito Hospital in Rome confirmed that the same parasite he had seen in Algeria was also present in Italian malaria patients, thus establishing the universality of his discovery. Laveran gradually began to convince more scientists with the evidence he accumulated between 1880 and 1882. Notably, leading physicians and scientists working on malaria in Italy, such as Camillo Golgi, Giovanni Battista Grassi, Ettore Marchiafava, Angelo Celli, and Amico Bignami, closely examined Laveran's findings. Camillo Golgi's microscopic studies in 1885-1886 confirmed that Laveran's parasite had different forms and developmental cycles; he even showed that the parasite multiplied and burst within red blood cells, causing periodic fevers. Golgi found that Plasmodium parasites divided every 48 hours or 72 hours, thereby linking the clinical symptoms of malaria with the life cycle of the parasite. These findings strongly supported Laveran's discovery and convinced skeptics. By 1884, Laveran's claims had begun to be accepted by leading Italian scientists, which eased tensions among French scientific circles. That year, Laveran successfully convinced initially skeptical French microbiologists Louis Pasteur, Émile Roux, and Charles Chamberland of the accuracy of his findings. This significant scientific achievement led to the French Academy of Sciences awarding him the Prix Bréant prize in 1889, officially honoring the discovery of the malaria parasite.

Those parasitic bodies in the red blood cells, viewed with suspicion in 1880, had become the accepted agent of malaria by the 1890s. Some scientists even named the most dangerous type of malaria Laverania in his honour for a time (the agent of malignant tertian malaria, P. falciparum).

Even so, old beliefs in the scientific community were not erased overnight. The American physician R.C. Newton, for example, was still publishing articles in support of Tommasi-Crudeli's bacterial thesis and the miasma theory as late as the mid-1890s. In 1895 Newton went so far as to write that it had been proved that malaria was transmitted by air and water. These minority views, however, were overshadowed by one discovery after another and lost their influence.

By the end of the 1890s, it had been established that malaria was caused by a parasite, and the idea that part of the parasite's life cycle could take place outside the human body had gained weight. As early as the early 1880s, while describing the parasite, Laveran had already considered the possibility that this organism might have a developmental stage in a host or environment other than humans. In fact, he was among the first researchers to suggest that the malaria parasite might be found in mosquitoes outside the human body. This hypothesis was developed theoretically by Patrick Manson in the 1890s and was finally confirmed when Ronald Ross proved it experimentally in 1897.

Laveran and the Mosquito Theory

Laveran followed Ross's work with great interest and admiration; Ross's 1897 demonstration that the parasite develops in the midgut of mosquitoes, and the subsequent 1898 proof by Italian scientists that Anopheles mosquitoes transmit malaria to humans, further reinforced the importance of Laveran's own discovery. Laveran had been among the supporters of Manson's mosquito-malaria theory since 1894, and after Ross's findings he became an advocate of anti-mosquito campaigns in France. In 1901, for instance, he investigated the malaria epidemic on the French island of Corsica and reported on the need to bring mosquitoes under control; on the basis of that report, the French Academy of Medicine made Laveran honorary president and, in 1902, founded the Corsica Anti-Malaria League.

In summary, Laveran's unusual discovery in 1880, initially met with skepticism by his colleagues, eventually gained acceptance as a medical fact after being verified by scientists from several countries over the following years. It was previously unknown that no protozoa lived in human red blood cells; Laveran's microscope discovery opened up a new horizon in this regard. Shortly thereafter, young researchers began searching for similar parasites in animals as well.

At the End of the 19th Century and the Beginning of the 20th Century: Scientific Context and Laveran's Contemporaries

General Trends in the Science of the Era and Their Historical Context

The period in which Laveran worked is remembered in the history of medicine and biology as the golden age of microbiology (roughly 1870-1910). During this period, under the leadership of Pasteur and Koch, the bacteria responsible for many infectious diseases were identified, and the germ theory displaced the older miasma belief. These developments strengthened the conviction in the medical community that every disease might have a specific microbial cause. A striking point, however, is that almost all of the pathogens discovered in this period were bacteria; fungi and viruses were poorly known, and protozoa were recognised as agents of human disease only in a handful of cases outside veterinary medicine. Laveran's 1880 discovery thus broadened the medical world's horizons, showing that single-celled animal organisms (protozoa) could also cause fatal disease in humans. This in turn led to parasitology gaining importance as a discipline within the medical sciences.

One notable feature of this period was the emergence of tropical medicine or exotic diseases field. At the end of the 19th century, when European empires established colonies in Africa, Asia, and Latin America, European scientists encountered tropical diseases more frequently. Malaria, yellow fever, sleeping sickness, cholera, and plague were ravaging both local populations and Western officials in colonial territories. This situation prompted metropolitan scientific communities to focus on tropical diseases. In 1898, Tropical Medicine Schools were founded in London and Liverpool; research departments for tropical diseases were opened within the Pasteur Institute in France; international conferences began to be organized. Laveran was an active part of this process: as interest in tropical diseases increased in France in the 1890s, he set up a laboratory at the Pasteur Institute as an honorary professor in 1896 and devoted himself entirely to parasitic research by leaving his military position. In 1908, he founded the Société de Pathologie Exotique (Exotic Pathology Society) in Paris, serving as its president for 12 years. Thus, he led the institutionalization of research on tropical diseases in France.

The late 19th century saw significant breakthroughs from a scientific perspective. Microscopic techniques were rapidly advancing: by the 1870s, immersion objectives developed in that decade and aniline dyes made microorganisms more visible. A few years after Laveran's discovery, Romanowsky-type special stains (e.g., methylene blue-eosin mixtures) were found, and by the year 1900, parasites could be distinguished within red blood cells using this method due to their characteristic colors. Consequently, the parasite Laveran first demonstrated in fresh blood was further studied by subsequent researchers using more advanced microscopes and staining methods.

Contemporaries of Laveran and the Impact of His Work on Scientists

In his time, there were scientists who both confirmed Laveran's discovery and added new dimensions to his work. Camillo Golgi, for example, elucidated the life cycle stages of the malaria parasite in the blood and explained fever cycles just a few years after Laveran, thereby obtaining significant findings that supported Laveran's research. Italian researchers Marchiafava, Celli, Bignami, and Grassi also contributed to understanding how malaria was transmitted through mosquitoes, particularly. In a classic experiment led by Giovanni Battista Grassi in 1898, it was demonstrated that when infected individuals' blood-sucking Anopheles mosquitoes bit healthy people several days later, they transmitted malaria to them. These experiments conclusively showed that the life cycle of the parasite discovered by Laveran continued outside its human host in the mosquito. Thus, Laveran's discovery combined with the work of contemporaries such as Ross and Grassi revealed the complete life cycle of malaria (human liver and blood stages + mosquito midgut and salivary gland stages) within a few years.

Laveran's work also influenced leading tropical medicine authorities of his time, including Patrick Manson. After learning about Laveran's discovery, Manson was inspired to explore the possibility that the malaria parasite could be transmitted by mosquitoes, building upon his own research into filarial parasites (he had previously proven in 1877 that a mosquito can carry filarial larvae).

Laveran's influence extended beyond malaria researchers alone. His success served as a motivation for discovering the causes of other tropical diseases as well. For instance, British physician David Bruce adopted Laveran's method while investigating the cause of nagana, a disease that was killing cattle in Africa in 1894: by examining the blood of infected animals under a microscope, he discovered a motile protozoan (Trypanosoma brucei) responsible for the disease, and demonstrated its link to nagana. In 1903, Bruce proved that a similar parasite (T. brucei subspecies) caused Sleeping Sickness in humans in Uganda.

Laveran's Other Work at the Pasteur Institute

Laveran did not confine himself to malaria but turned his attention to other parasitic diseases as well. From the 1900s onwards he concentrated in particular on trypanosomes, identifying new species of trypanosomes in a variety of animals. Together with his colleague Félix Mesnil he discovered numerous blood parasites in European eels, in fish, and in frogs; in their comprehensive work Trypanosomes et Trypanosomiases, published in 1904, they introduced more than 30 new species to the scientific world. Laveran studied the trypanosome that causes African sleeping sickness — naming it Trypanosoma gambiense (today human African sleeping sickness is known to be caused by the subspecies T. gambiense and T. rhodesiense) — and conducted research particularly on its treatment. Laveran's laboratory is recorded as having contributed to the discovery of some of the first effective drugs against trypanosome infections (such as arsenic derivatives), and his work in this area produced significant results.

Laveran's other area of work was also leishmaniasis (cutaneous and visceral leishmaniasis). During his time in Algeria, while working in the Biskra region where a local disease known as Biskra nodule occurred, he studied a skin disease there and thought that it could be caused by a protozoan. Although he did not make successful observations, he prophetically predicted that a similar parasite could cause a fatal disease affecting internal organs (visceral leishmaniasis). In fact, at the beginning of the 1900s, two doctors named Leishman and Donovan discovered a new parasite in the spleen aspirations of patients with kala-azar in India; Laveran examined the samples sent by these doctors along with Mesnil and gave the parasite the name Piroplasma donovanii. The same year, this name was corrected to Leishmania donovani, and it officially entered the literature as the causative agent of kala-azar. Laveran reported the first case of visceral leishmaniasis in children in Tunisia and published a book about leishmaniasis in 1917.

As seen, Laveran has continued along the path he opened up by his own discovery, playing a pioneering role in the discovery of new pathogenic protozoa and inspiring his contemporaries in the scientific community.

Laveran's Nobel Prize

When he was awarded the Nobel Prize in 1907, the award's justification went beyond just malaria parasites, highlighting his work on the role of protozoans as disease agents. Laveran donated half of the prize money to establish a Tropical Diseases Laboratory at the Pasteur Institute, thereby encouraging young researchers to pursue research in this field.

Laveran was already known in the scientific community before his discovery of malaria parasites. He received the Bréant Prize from the French Academy of Sciences in 1889 for his discovery of the malaria parasite and the Edward Jenner Medal from the Royal Society of Medicine in 1902.

The Effects of Laveran's Work on Clinical and Modern Medicine

Influence on Malaria Treatment

Although Laveran's discovery of the malaria parasite did not directly produce a new therapeutic molecule, it solidified the scientific basis of malaria treatment. Recognising that malaria is a parasite-caused disease made it clear that the goal of therapy had to be the elimination of that parasite. Laveran's observations indicated that drugs like quinine acted by clearing the parasite from the bloodstream. This finding allowed clinicians to apply quinine therapy with more confidence and led them to suspect the parasite itself when drug-resistant cases appeared. In the first half of the 20th century, many scientists who followed in Laveran's footsteps set out to develop new antimalarial drugs. Paul Ehrlich, for example, tried synthetic dyes and arsenic compounds against the malaria parasite; in 1920s Germany, plasmochin (pentaquin), one of the first synthetic anti-Plasmodium drugs, was developed. One of the greatest breakthroughs was the compound synthesised by German chemists in the 1930s under the name Resoquin, later known as the famous drug chloroquine. After the Second World War, chloroquine became the mainstay of malaria therapy and largely replaced the very high doses of quinine used in Laveran's time. The appearance of the first chloroquine-resistant malaria parasites in the late 1950s, however, showed that drug development must never stop. In fact, continued research produced prophylactic drugs such as mefloquine in the 1970s and potent treatments such as artemisinin, derived from an ancient Chinese herbal remedy.

Throughout all these developments, scientists following in Laveran's path were able to produce the parasite in the laboratory, conduct experiments using animal models, and test new drugs. As the founder of parasitology, Laveran transformed malaria treatment from a trial-and-error practice into a targeted therapeutic field.

The discovery of Laveran has left a lasting impact on malaria diagnosis and treatment practices: microscopic blood smear examination. From Laveran to present day, the gold standard in malaria diagnosis remains examining the patient's blood smear under a microscope to detect the presence of the parasite. Developed in the early 1900s using specialized dyes such as Giemsa, the forms of parasites discovered by Laveran can still be distinguished today, allowing the type of Plasmodium carried by the patient to be identified. This enables the selection of appropriate treatment.

Long-term Effects in Parasitology and Fighting Tropical Diseases

Perhaps the greatest impact of Laveran's work was to pave the way for a discipline called parasitology to be born in the medical world. After his 1880 discovery, the concept of pathological protozoa entered the literature and rapidly expanded. Indeed, today, malaria, amoebic dysentery, toxoplasmosis, cryptosporidiosis, sleeping sickness, Chagas disease, and leishmaniasis — among many other diseases caused by protozoan parasites — are major health problems that affect millions of people every year. The medical parasitology research begun in Laveran's day became institutionalised over the course of the 20th century, taking shape as chairs and institutes in many universities. By founding the Tropical Diseases laboratory at the Pasteur Institute in France, Laveran established the French school; in other countries, his students or scientists working in the same tradition launched national programmes. Through all this, the fight against tropical diseases became a global effort.

The influence of Laveran's work on clinical medicine has not been limited to malaria. His contributions changed the approach doctors working in the tropics took to many diseases. African sleeping sickness, for example — long unexplained and attributed to bad air or divine wrath — could finally be brought under control once Laveran's and Bruce's discoveries assigned it a concrete cause (a trypanosome) and a concrete vector (the tsetse fly). The microscopic-examination methods Laveran developed have been applied to the diagnosis of diseases such as leishmaniasis and syphilis; for example, looking for Leishman-Donovan bodies in a spleen aspirate has become standard practice in diagnosing kala-azar.

Modern Malaria Control Strategies and Their Reflection Today

The scientific progress that began with Laveran's discovery 140 years ago still forms the foundation of the fight against malaria today. Modern malaria-control strategies generally move along two main axes: treating the patient (eliminating the parasite), and preventing transmission of the disease (vector control). Both axes rest on the findings of Laveran and his contemporaries. The discovery of the parasite made it possible to develop effective drugs; the discovery of the vector revealed the importance of fighting the mosquito. One of the simplest yet most effective methods of vector control is the widespread use of mosquito nets. With modern technology, methods such as detecting mosquito breeding areas via satellite imaging and then applying larvicides are also used. All these strategies depend on understanding the life cycle of the disease — and the first link in that life cycle was discovered by Laveran.

In recent years, significant progress has been made in malaria control through vaccination. After decades of research, RTS,S was approved in 2021 to provide partial protection against malaria. This vaccine aims to induce immunity against one of the surface proteins of the parasite discovered by Laveran.

Nobel Prize in Medicine

In 1907, Laveran was awarded the Nobel Prize in Medicine for his work on the role of protozoans in causing diseases. This award highlighted the significance of Laveran's discovery of the malaria parasite and his research into other diseases associated with protozoa. In his speech at the Nobel Prize ceremony, Laveran explained how he discovered the malaria parasite and emphasized its importance in understanding and treating the disease. Laveran used half of the prize money to establish the Tropical Medicine Laboratory at the Pasteur Institute and donated the other half to the institute.

Publications and Works

Laveran investigated the causes and modes of transmission of these diseases and worked on developing treatments for them. He also wrote many scientific papers and books in the field of tropical medicine. Some of his publications include:

• Trypanosomes and Trypanosomiasis (with Félix Mesnil; 1904)
• Treatise on Malarial Fevers with a Description of the Malaria Microbe (1884)
• Treatise on Army Diseases and Epidemics (1875)
• Parasitic nature of malaria accidents, description of a new parasite found in the blood of patients suffering from palustrine fever (1881)
• Malaria and its Haematozoon (1891)

Conclusion

Dr. Alphonse Laveran made important contributions to the history of medicine through his work on diseases related to protozoa. His discovery of the malaria parasite was a turning point in understanding and treating malaria, since it revealed that the cause of malaria was not environmental factors but a parasite, opening the way for new strategies to control the disease. Laveran's work contributed to the development of research in tropical medicine and to the discovery of new treatments. His being awarded the Nobel Prize in Medicine is a sign of the valuable contributions he made to science. Laveran played a pioneering role in establishing the field of protozoology in medicine and helped us understand the diversity and impact of protozoan parasites. His dedication to science and his groundbreaking research continue to inspire scientists today.